Reaction

Cerebrovascular Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,004 reports · 55 co-occurring drugs

As of the last recalculation, Cerebrovascular Disorder appears in 3,004 FAERS reports alongside 55 co-occurring drug terms. The strongest observed disproportionality signal is PARICALCITOL (PRR 31.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Paricalcitol	62	31.0	31.2
Celecoxib	283	16.3	16.4
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	14	11.9	11.9
Salmeterol Xinafoate	11	8.9	8.9
Olanzapine Pamoate	45	7.7	7.7
Magnesium Sulfate In Water For	14	7.6	7.6
Magnesium Sulfate Heptahydrate	14	7.5	7.5
Magnesium Sulfate	14	7.5	7.5
Epoetin Alfa	12	7.0	7.0
Hyoscyamine Sulfate	9	6.8	6.8
Metolazone	9	5.6	5.6
Heparin Sodium	11	5.6	5.6
Alteplase	12	5.6	5.6
Nitroglycerin	42	5.5	5.5
Testosterone Cypionate	7	5.4	5.4
Enalapril Maleate	19	5.3	5.3
Quinapril Hydrochloride	6	5.3	5.3
Agalsidase Beta	7	5.3	5.3
Digoxin	52	5.1	5.1
Gemfibrozil	11	5.0	5.0
Niacin	8	4.8	4.8
Gentamicin	9	4.8	4.8
Isosorbide Mononitrate	14	4.7	4.7
Blinatumomab	7	4.7	4.7
Romosozumab-Aqqg	9	4.6	4.6
Haloperidol Lactate	16	4.5	4.5
Amlodipine Besylate And Valsartan	7	4.4	4.4
Raloxifene Hydrochloride	9	4.3	4.3
Donepezil Hydrochloride	22	4.2	4.2
Erythropoietin	12	4.1	4.1
Hydroxyurea	12	3.9	3.9
Ranibizumab	15	3.9	3.9
Dolutegravir Sodium	5	3.8	3.8
Nilotinib	16	3.8	3.8
Peginterferon Beta-1A	7	3.7	3.7
Estrogens, Conjugated	30	3.5	3.5
Dorzolamide Hydrochloride And Timolol Maleate	4	3.5	3.5
Oseltamivir	4	3.5	3.5
Bleomycin Sulfate	5	3.4	3.4
Pseudoephedrine Hcl	5	3.1	3.1
Methoxy Polyethylene Glycol-Epoetin Beta	5	3.1	3.1
Nevirapine	4	3.1	3.1
Dabigatran Etexilate Mesylate	29	2.8	2.8
Pseudoephedrine Hydrochloride	4	2.7	2.7
Dabigatran Etexilate	29	2.6	2.6
Medroxyprogesterone Acetate	18	2.5	2.5
Travoprost	3	2.4	2.4
Bosutinib	3	2.3	2.3
Conjugated Estrogens And Medroxyprogesterone Acetate	7	2.1	2.1
Drospirenone And Ethinyl Estradiol	13	2.0	2.0
Abiraterone	4	2.0	2.0
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	9	2.0	2.0
Rimegepant Sulfate	3	1.6	1.6
Aflibercept	6	1.3	1.3
Lifitegrast	3	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.